Objectives

After participating in this educational activity, attendees should be able to:

1| Describe the cefazolin inoculum effect in vitro and recognize possible in vivo impact
2| Discuss landscape of clinical data, limitations, and possible improvements to trial designs in comparisons of therapy for MSSA
3| Identify potential testing methods to apply to patient care in the future
 
Presenter(s): 
Michael Lorenzo, PharmD, BCIDP, AAHIVP
Clinical Pharmacy Specialist, Infectious Diseases
Baystate Medical Center
 
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Michael Lorenzo, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
08/18/2025 - 2:00pm to 3:00pm EDT
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.